The 5th Veterinary Symposium

Present Experience, Future Vision

This important annual Veterinary Symposium is now recognised as a key event in the European calendar of all those working in the veterinary arena.

Aim

This annual Symposium is for all those involved with Veterinary medicines and brings together representatives of industry and regulatory authorities to discuss and understand today’s regulatory requirements, and debate the future plans for regulation. This is the key annual European regulatory forum for all those involved in the veterinary medicines sector and aims to bring you all the latest information and importantly what is coming over the horizon. There will also be ample time to network in the breaks and also view services from exhibitors in the industry and the regulatory bodies.

Who should attend

All those working in veterinary medicines from industry and the regulatory authorities who wish to know how legislation will affect their daily work.

Programme includes

KEYNOTE PRESENTATION - DG Sanco priorities, Community Animal Health Policy

• Strategy for Regulation of Veterinary Medicines
• Referrals: what can we learn from them?
• Implementation of the Variations Regulation 1234/2008
• Implementation of New Requirements and Procedures

There will also be ample time for questions during the panel discussions throughout the day.

Free bonus session on Monday afternoon 4th October: 'Electronic Submissions - Are you Ready? Are we Ready?' covering EU status of Electronic Submissions for Human and Veterinary. NeeS, eNTA and eCTD: how easy to produce, company benefits? Electronic gateways"

Speaker include

• Steve Dean, Chief Executive, Veterinary Medicines Directorate, UK
• Mario Nagtzaam, European Commission
• Jackie Atkinson, Director, Veterinary Medicines Directorate, UK
• David Mackay, Head of Veterinary Medicines and Product Data Management, European Medicines Agency
• Esther Werner, Chair to CMD(v), Department of Veterinary Medicine, PEI, Germany
• Michael Holzhauser-Alberti, Deputy Head of Unit, AFFSA, France
• Anja Holm, Chair CVMP, Lægemiddelstyrelsen, Denmark
• Yara Antonissen, Technical Assistant, IFAH Europe, Belgium
• Melanie Leivers, Head of Veterinary Regulatory and Organisational Support, European Medicines Agency
• Guillaume Agède, Ceva Santé Animale, France
• Rick Clayton, Technical Director, IFAH Europe, Belgium
• Karen Quigley, Scientific Administrator, European Medicines Agency
• Rhona Banks, Director Regulatory Affairs, Triveritas, UK
• Corinne Philippe-Reversat, Merial SAS, France
• Ray Harding, Consultant, Cyton Biosciences Ltd, UK
• Etienne Bonbon, DG Sanco, European Commission
• Gavin Hall, Head of Licensing Administration, Veterinary Medicines Directorate, UK

The working party comprises

• Ray Harding, Managing Director, Cyton Biosciences, UK
• Steve Dean, Director & Chief Executive, Veterinary Medicines Directorate, UK
• Trish Logie, Head of Communications and Quality Management, Veterinary Medicines Directorate, UK
• Rick Clayton, Technical Director, IFAH-Europe, Belgium
• Mária Szabó, Central Agriculture Office, Directorate of Veterinary Medicinal Products, Hungary
• Melanie Leivers, Veterinary Regulatory Organisational Support, EMA
• Guillaume Agède, Head of European Regulatory Affairs, CEVA Santé Animale, France
• Rhona Banks, Director Regulatory Affairs, Triveritas, UK